On June 20th, Gelunhui reported that Sino Biopharmaceuticals (01177.HK) announced that between June 14th and June 20th, 2024, the trustee further purchased a total of 18.336 million shares of the company's stock on the market in accordance with the terms and conditions of the stock incentive plan, for subsequent share incentives to selected participants.
中国生物制药(01177.HK)：正大天晴根据股份激励计划购买股份
Sino Biopharm (01177.HK): Zhongda Tianqing purchases shares according to the stock incentive plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.